Author: John Murphy, MD CEO & President, COVID-19 Long-haul Foundation Abstract Vertigo and disequilibrium are increasingly recognized as disabling sequelae of Long COVID, yet remain under-characterized in clinical literature. This…[...]
Read More
If the findings of their study are confirmed by other research centers, the biomarker could be the first specific and quantifiable indicator for confirming long COVID. Currently, clinicians confer a…[...]
Read More
Japanese researchers uncover the molecular signature of Long COVID brain fog, a breakthrough that could bring real treatments closer than ever. Summary: Researchers in Japan have pinpointed a biological cause…[...]
Read More
Summary: A massive NIH-backed study reveals that COVID-19’s toll on smell may be more widespread and lasting than most realize. Even patients without noticeable symptoms often performed poorly on scent…[...]
Read More
Abdullah M. Almutairi • Mushabab A. Alshahrani • Khalid A. Albalawi et.al., DOI: 10.7759/cureus.95744 Abstract Coronavirus disease 2019 (COVID-19) vaccines have been instrumental in mitigating the pandemic, but rare post-vaccination immune-related events have been reported. Due…[...]
Read More
People’s risk of heart attack or stroke skyrockets after a bout with the flu or COVID, a new evidence review says. Folks are four times more likely to have a heart attack…[...]
Read More
Matheus Guidini Lima • Francisco Pires • Leopoldo Mandic Ferreira Furtado, et. al. ,DOI: 10.7759/cureus.93758 Abstract Traumatic brain injury (TBI) is a significant worldwide public health concern and is among the top causes of death…[...]
Read More
Author: John Murphy, President, COVID-19 Long-haul Foundation Abstract Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), presents with a striking female predominance and heterogeneous symptom profiles. Emerging evidence suggests…[...]
Read More
Grant McGee Talkington, Paresh Kolluru, Timothy E. Gressett, et. al., Frontiers in Neurology One lingering effect of the COVID-19 pandemic created by SARS-CoV-2 is the emergence of Long COVID (LC),…[...]
Read More
Author: John Murphy, CEO COVID 19 Long-haul Foundation Abstract The SARS-CoV-2 spike glycoprotein, central to viral entry and the target of mRNA vaccine platforms, has emerged as a persistent antigen…[...]
Read More